Universe Pharmaceuticals Inc (UPC)

$4.70 -0.39 (-7.66%)
Market Cap 218,000.00
Revenue (ttm) 23.02M
Net Income (ttm) -8.73M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -37.92%
Debt to Equity Ratio 0.18
Volume 21,000
Avg Vol 422,489
Day's Range N/A - N/A
Shares Out 43,000.00
Stochastic %K 7%
Beta 1.52
Analysts Strong Buy
Price Target N/A

Latest News on UPC

Universe Pharmaceuticals INC Announces Share Consolidation

Mar 20, 2025, 8:30 AM EDT - 2 months ago

Universe Pharmaceuticals INC Announces Share Consolidation

Universe Pharmaceuticals INC Receives Staff Determination Notice from Nasdaq Related to Delayed Annual Report

Feb 25, 2025, 4:10 PM EST - 3 months ago

Universe Pharmaceuticals INC Receives Staff Determination Notice from Nasdaq Related to Delayed Annual Report

Universe Pharmaceuticals INC Receives Nasdaq Delisting Notice Subject to Hearing Request

Feb 3, 2025, 4:10 PM EST - 4 months ago

Universe Pharmaceuticals INC Receives Nasdaq Delisting Notice Subject to Hearing Request

Univest Securities, LLC Announces Closing of $15 Million Registered Direct Offering for its Client Universe Pharmaceuticals INC (NASDAQ: UPC)

Dec 10, 2024, 5:00 PM EST - 6 months ago

Univest Securities, LLC Announces Closing of $15 Million Registered Direct Offering for its Client Universe Pharmaceuticals INC (NASDAQ: UPC)

Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Nov 1, 2024, 4:00 PM EDT - 7 months ago

Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2024

Sep 20, 2024, 4:15 PM EDT - 9 months ago

Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2024

Universe Pharmaceuticals INC Reports Fiscal Year 2023 Financial Results

Jan 30, 2024, 4:30 PM EST - 1 year ago

Universe Pharmaceuticals INC Reports Fiscal Year 2023 Financial Results

Universe Pharmaceuticals INC Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares

Aug 4, 2023, 8:30 AM EDT - 1 year ago

Universe Pharmaceuticals INC Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares

Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2022

Aug 16, 2022, 8:00 AM EDT - 3 years ago

Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2022

Universe Pharmaceuticals INC Announces Strategic Partnership with Lian-Ou Health to Develop its Digital Marketing and Sales on E-Commerce Platforms

Mar 30, 2022, 8:00 AM EDT - 3 years ago

Universe Pharmaceuticals INC Announces Strategic Partnership with Lian-Ou Health to Develop its Digital Marketing and Sales on E-Commerce Platforms

Universe Pharmaceuticals INC Announces Strategic Alliance with Jinggangshan University for Study on the Chemical Constituents of Certain Traditional Chinese Medicine

Dec 29, 2021, 8:00 AM EST - 3 years ago

Universe Pharmaceuticals INC Announces Strategic Alliance with Jinggangshan University for Study on the Chemical Constituents of Certain Traditional Chinese Medicine

Universe Pharmaceuticals INC Appoints Mr. Baochang Liu as Chief Operating Officer

Dec 15, 2021, 4:30 PM EST - 3 years ago

Universe Pharmaceuticals INC Appoints Mr. Baochang Liu as Chief Operating Officer

Universe Pharmaceuticals INC Announces Strategic Alliance with Kitanihon Pharmaceutical Co., Ltd. to Address the Market Demand for Kampo Medicine and High-end Traditional Chinese Medicine

Dec 13, 2021, 8:30 AM EST - 3 years ago

Universe Pharmaceuticals INC Announces Strategic Alliance with Kitanihon Pharmaceutical Co., Ltd. to Address the Market Demand for Kampo Medicine and High-end Traditional Chinese Medicine

Universe Pharmaceuticals INC to Announce Unaudited Financial Results for The First Six Months of Fiscal Year 2021 on August 2, 2021

Jul 30, 2021, 8:00 AM EDT - 4 years ago

Universe Pharmaceuticals INC to Announce Unaudited Financial Results for The First Six Months of Fiscal Year 2021 on August 2, 2021

Universe Pharmaceuticals INC Announces Full Exercise of Underwriter's Over-Allotment Option in the Public Offering

Mar 31, 2021, 4:15 PM EDT - 4 years ago

Universe Pharmaceuticals INC Announces Full Exercise of Underwriter's Over-Allotment Option in the Public Offering

Universe Pharmaceuticals INC Announces Closing of Initial Public Offering

Mar 25, 2021, 4:20 PM EDT - 4 years ago

Universe Pharmaceuticals INC Announces Closing of Initial Public Offering

Universe Pharmaceuticals INC Announces Pricing and Trading of Initial Public Offering

Mar 23, 2021, 8:50 AM EDT - 4 years ago

Universe Pharmaceuticals INC Announces Pricing and Trading of Initial Public Offering